M3, Inc. (OTCMKTS:MTHRF) Sees Large Growth in Short Interest

M3, Inc. (OTCMKTS:MTHRFGet Free Report) was the recipient of a significant growth in short interest during the month of September. As of September 30th, there was short interest totaling 5,772,300 shares, a growth of 44.7% from the September 15th total of 3,989,800 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group lowered M3 to a “neutral” rating in a report on Thursday, October 9th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has an average rating of “Hold”.

Read Our Latest Analysis on MTHRF

M3 Price Performance

Shares of MTHRF opened at $14.47 on Friday. M3 has a one year low of $8.33 and a one year high of $14.47. The business has a fifty day moving average of $13.90 and a 200 day moving average of $12.88.

About M3

(Get Free Report)

M3, Inc provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, and Overseas. It operates m3.com, a members-only web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctors.net.uk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain.

Read More

Receive News & Ratings for M3 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M3 and related companies with MarketBeat.com's FREE daily email newsletter.